CureVac starts Phase 3 clinical trial of its Covid-19 vaccine candidate

Tübingen-based CureVac said the Phase 3 trial will include more than 35,000 volunteers in Europe and Latin America
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.